BDBM256141 US9487462, 30

SMILES OC(=O)c1c[nH]c(CN(Cc2ccc(F)cc2)Cc2ccc(OCc3ccccc3)cc2)n1

InChI Key InChIKey=QLTNFRCPUOPISS-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 256141   

TargetCollagenase 3(Human)
Pharmahungary 2000

US Patent
LigandPNGBDBM256141(US9487462, 30)
Affinity DataIC50: 1.76E+3nMpH: 7.5 T: 2°CAssay Description:Stock solution of substrate (Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) was prepared in DMSO at a concentration of 6 mM. Assays were performed in an as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetCollagenase 3(Human)
Pharmahungary 2000

US Patent
LigandPNGBDBM256141(US9487462, 30)
Affinity DataIC50: 3.30E+3nMpH: 7.5 T: 2°CAssay Description:Stock solution of substrate (Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) was prepared in DMSO at a concentration of 6 mM. Assays were performed in an as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Pharmahungary 2000

US Patent
LigandPNGBDBM256141(US9487462, 30)
Affinity DataIC50: 3.90E+3nMpH: 7.5 T: 2°CAssay Description:Stock solution of substrate (Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) was prepared in DMSO at a concentration of 6 mM. Assays were performed in an as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

Target72 kDa type IV collagenase(Human)
Pharmahungary 2000

US Patent
LigandPNGBDBM256141(US9487462, 30)
Affinity DataIC50: 6.60E+3nMpH: 7.5 T: 2°CAssay Description:Stock solution of substrate (Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) was prepared in DMSO at a concentration of 6 mM. Assays were performed in an as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetMatrix metalloproteinase-9(Human)
Pharmahungary 2000

US Patent
LigandPNGBDBM256141(US9487462, 30)
Affinity DataIC50: 1.30E+4nMpH: 7.5 T: 2°CAssay Description:Stock solution of substrate (Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) was prepared in DMSO at a concentration of 6 mM. Assays were performed in an as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

Target72 kDa type IV collagenase(Human)
Pharmahungary 2000

US Patent
LigandPNGBDBM256141(US9487462, 30)
Affinity DataIC50: 1.50E+4nMpH: 7.5 T: 2°CAssay Description:Stock solution of substrate (Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) was prepared in DMSO at a concentration of 6 mM. Assays were performed in an as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Pharmahungary 2000

US Patent
LigandPNGBDBM256141(US9487462, 30)
Affinity DataIC50: 3.30E+4nMpH: 7.5 T: 2°CAssay Description:Stock solution of substrate (Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) was prepared in DMSO at a concentration of 6 mM. Assays were performed in an as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetMatrix metalloproteinase-9(Human)
Pharmahungary 2000

US Patent
LigandPNGBDBM256141(US9487462, 30)
Affinity DataIC50: 1.00E+5nMpH: 7.5 T: 2°CAssay Description:Stock solution of substrate (Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) was prepared in DMSO at a concentration of 6 mM. Assays were performed in an as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent